Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

A Conversation with ChatGPT about the Impact of the COVID-19 Pandemic on Education: Comparative Review Based on Human–AI Collaboration
Turgut Karaköse, Murat Demirkol, Nurcihan Aslan, et al.
Educational Process International Journal (2023) Vol. 12, Iss. 3
Open Access | Times Cited: 43
Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters
Emmanouil Karampinis, Myrto-Maria Papadopoulou, Kleoniki Chaidaki, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 178-178
Open Access | Times Cited: 11
Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis
Milena Adina Man, Daniela Rosca, Felix Bratosin, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 189-189
Open Access | Times Cited: 11
Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis
Silvia Fernández-García, Laura del Campo-Albendea, Dharshini Sambamoorthi, et al.
BMJ Global Health (2024) Vol. 9, Iss. 4, pp. e014247-e014247
Open Access | Times Cited: 6
Evaluation of anti-SARS-CoV-2 RBD antibody response after booster dose of SpikoGen® in individuals with two previous doses of Sinopharm and its association with HLA-DR and -DQ alleles
Amir Hossein Hajijafary, Somayeh Malekmohammad, Awat Feizi, et al.
Human Immunology (2025) Vol. 86, Iss. 1, pp. 111227-111227
Closed Access
Structural and functional properties of the SARS-CoV-2 spike protein: Potential vaccine and drug development for COVID-19
Reed L. Berkowitz, David A. Ostrov
Elsevier eBooks (2025), pp. 57-74
Closed Access
Global strategies against COVID-19: The role of public health measures, vaccination, and technology
Katherine Wang
Theoretical and Natural Science (2025) Vol. 69, Iss. 1, pp. 30-34
Closed Access
Long-term assessment of anti-SARS-CoV-2 antibody levels post-pandemic: Tracking the dynamics after two, three, and four COVID-19 vaccine doses
Fatemeh Ashrafian, Mostafa Salehi‐Vaziri, Ehsan Mostafavi, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102676-102676
Open Access
The Second Life for Unused COVID-19 Vaccines: Towards Biosensing Application
Vincentas Mačiulis, Asta Lučiūnaitė, Mantvydas Usvaltas, et al.
Talanta (2025), pp. 127647-127647
Closed Access
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus
Richard Adeleke, Julie Sahler, Annette Choi, et al.
Science Advances (2025) Vol. 11, Iss. 5
Closed Access
The ZNF717-rs2918520 genotype contributes to COVID-19 severity: a Taiwanese cohort study
Yang-Hsiang Lin, Jen Yu, Yu-Chuan Teng, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
Nawal Al Kaabi, Yun Yang, Jing Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 28
Recombinant vaccines in 2022: a perspective from the cell factory
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, et al.
Microbial Cell Factories (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile
Abdulaziz Ibrahim Alzarea, Yusra Habib Khan, Ahmed D. Alatawi, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 924-924
Open Access | Times Cited: 26
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
Effectiveness of COVID-19 Vaccination on Transmission: A Systematic Review
Anouk Oordt-Speets, Júlia Spinardi, Carlos Mendoza, et al.
COVID (2023) Vol. 3, Iss. 10, pp. 1516-1527
Open Access | Times Cited: 12
Antiviral activity of the host defense peptide piscidin 1: investigating a membrane-mediated mode of action
Tristan Bepler, Michael D. Barrera, Mary T. Rooney, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 3
Enhancing explainable SARS-CoV-2 vaccine development leveraging bee colony optimised Bi-LSTM, Bi-GRU models and bioinformatic analysis
Dilber Uzun Ozsahin, Zubaida Said Ameen, Abdurrahman Shuaibu Hassan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Improving vaccine equity by increasing vaccine thermostability
Jonathan Hare, Renske Hesselink, Alexander Bongers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 757
Closed Access | Times Cited: 2
COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
Aleksandra Kubas, Ewa Małecka‐Panas
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2676-2676
Open Access | Times Cited: 13
A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis
Malik Suliman Mohamed, Ahmed Mohamed, Rawaf Alenazy, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 315-315
Open Access | Times Cited: 6
Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia
Tauqeer Hussain Mallhi, Yusra Habib Khan, Muhammad Hammad Butt, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1799-1799
Open Access | Times Cited: 10
Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia
Ni Luh Ayu Megasari, Laura Navika Yamani, Juniastuti Juniastuti, et al.
PeerJ (2023) Vol. 11, pp. e16142-e16142
Open Access | Times Cited: 5
COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations
Muhammad Akmal Raheem, Muhammad Ajwad Rahim, Ijaz Gul, et al.
Life Sciences (2024), pp. 122861-122861
Open Access | Times Cited: 1
Reported Adverse Events and Associated Factors in Korean Coronavirus Disease 2019 Vaccinations
Hyunjin Park, Eunsun Lim, Seunghee Jun, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 42
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top